Ferring reacquires rights to desmopressin nasal spray

Ferring Pharmaceuticals has announced that it has reacquired desmopressin acetate (DDAVP), which is approved as a nasal spray and a number of other formulations, from Sanofi. Ferring originally developed desmopressin, which is a synthetic form of vasopressin and is used to reduce frequent urination among other conditions. In 2007, the FDA announced that the intranasal . . . Read more

Gerresheimer opens Chinese development center

Device manufacturer Gerresheimer has announced the opening of a new development center in Dongguan City, China, where the company has been manufacturing inhalers and other drug delivery devices since 2006. The company also has development centers in Germany and the US; all three centers include design, engineering, and development to prepared devices for production. Gerresheimer . . . Read more

Iconovo raises $1 million for inhaler development

According to Swedish device developer Iconovo, the company has raised $1 million in venture capital that it will use for development of dry powder inhalation devices. The company also said that Lennart Holm, chairman of the board of BillerudKorsnäs AB, Nexam AB, and Vigmed AB has increased his equity share in Iconovo. Since Iconovo was . . . Read more